Fineberg, H. V. 1979. Clinical chemistries: The high costs of low-cost diagnostic tests . In: S. H. Altman and R. Blendon, eds. Medical Technology: The Culprit Behind Health Care Costs? Washington, D.C.: U.S. Government Printing Office, pp. 144-165.
Hillman, B. J. 1986. Government health policy and the diffusion of new medical devices . Health Services Research 21:681-711.
IOM (Institute of Medicine). 1990a. Clinical Practice Guidelines: Directions for a New Program. M. J. Field and K. N. Lohr, eds. Washington, D.C.: National Academy Press.
IOM. 1990b. Medicare: A Strategy for Quality Assurance. Vol. I. K. N. Lohr, ed. Washington, D.C.: National Academy Press.
Neumann, P. J., and M. C. Weinstein. 1991. The diffusion of new technology: Costs and benefits to health care . In: Institute of Medicine. Medical Innovation at the Crossroads. Vol. II. The Changing Economics of Medical Technology. A. C. Gelijns and E. A. Halm, eds. Washington, D.C.: National Academy Press, pp. 21-34.
Schaffarzick, R. W. 1985. Cost containment: Technology assessment and health benefits determination . QRB/Quality Review Bulletin 11:222-225.
Walden, J. A., L. W. Stevenson, K. Dracup, J. Wilmarth, J. Kobashigawa, and J. Moriguchi. 1989. Heart transplantation may not improve quality of life for patients with stable heart failure. Heart & Lung 18:497-506.
Wennberg, J. E., A. G. Mulley, Jr., D. Hanley, R. P. Timothy, F. J. Fowler, Jr., N. P. Roos, et al. 1988. An assessment of prostatectomy for benign urinary tract obstruction: Geographic variations and the evaluation of medical care outcomes . Journal of the American Medical Association 259:3027-3030.